KDM6A is also mutated in numerous solid tumors such as bladder cancer, prostate cancer, and breast cancer [156], and depletion of KDM6A led to increased expression of EMT transcription factors, Snail, ZEB1, and ZEB2 [157]. Here, KDM6A is linked to breast carcinoma.